Downstream Processing (DSP) is a biotechnology process used to purify and concentrate biopharmaceuticals, such as proteins, antibodies, and enzymes. It is a critical step in the production of biopharmaceuticals, as it ensures the quality and safety of the final product. DSP involves a series of steps, such as filtration, chromatography, and ultrafiltration, to separate and purify the desired product from the rest of the components. The process is highly complex and requires specialized equipment and expertise. The DSP market is growing rapidly, driven by the increasing demand for biopharmaceuticals and the need for efficient and cost-effective production processes. The market is expected to continue to grow in the coming years, driven by technological advancements and the increasing demand for biopharmaceuticals. Some of the major companies in the DSP market include Merck KGaA, GE Healthcare, Thermo Fisher Scientific, Sartorius AG, and Pall Corporation. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
